Indian Journal of Ophthalmology

LETTER TO EDITOR
Year
: 2006  |  Volume : 54  |  Issue : 4  |  Page : 290--291

Authors' reply


Vasumathy Vedantham 
 Retina-Vitreous Service, Aravind Eye hospital and Postgraduate Institute of Ophthalmology, Madurai, Tamil Nadu, India

Correspondence Address:




How to cite this article:
Vedantham V. Authors' reply.Indian J Ophthalmol 2006;54:290-291


How to cite this URL:
Vedantham V. Authors' reply. Indian J Ophthalmol [serial online] 2006 [cited 2021 Jan 20 ];54:290-291
Available from: https://www.ijo.in/text.asp?2006/54/4/290/27970


Full Text

Dear Editor,

We appreciate the comments regarding our article 'Intravitreal injection of triamcinolone acetonide for diabetic macular edema: Principles and practice'.[1]

Although we do agree with the observation that diabetic maculopathy tends to worsen after cataract surgery, we feel uncomfortable with the idea of injecting a steroid intraoperatively. We feel this might lead to an increased incidence of endophthalmitis considering the immunocompromized status of such patients. A preoperative (before one month) or postoperative (after one month) intravitreal triamcinolone acetonide would be more preferable and safer in such situations.

We also do not advocate doing immediate intraoperative grid laser with Laser indirect ophthalmoscope firstly due to inaccuracy of precise gentle burns with this mode of delivery and secondly, due to exacerbation of inflammation from laser in the postoperative period leading to increased incidence of cystoid macular edema.

References

1Vedantham V, Kim R. Intravitreal injection of triamcinolone acetonide for diabetic macular edema: Principles and practice. Indian J Ophthalmol 2006;54:133-7.